Lifeboat Foundation

The machine-learning model could help scientists speed the development of new medicines.

This technique could help scientists better understand some biological processes that involve protein interactions, like DNA replication and repair; it could also speed up the process of developing new medicines.

“Deep learning is very good at capturing interactions between different proteins that are otherwise difficult for chemists or biologists to write experimentally. Some of these interactions are very complicated, and people haven’t found good ways to express them. This deep-learning model can learn these types of interactions from data,” says Octavian-Eugen Ganea, a postdoc in the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) and co-lead author of the paper.

Continue reading “Artificial intelligence system rapidly predicts how two proteins will attach” »

What are biomarkers? They are medical signals that can measure health in an accurate and reproducible way. Common examples include blood pressure readings, heart rate, and even genetic test results.

Modern digital devices measure several health parameters. Fitbit trackers use sensors such as accelerometers to tell how many steps we’ve taken in a day or how fast we’ve been walking. When can such novel health measures function as medical biomarkers?

Continue reading “The Future Of Medicine: Fighting Deadly Diseases With Smart Devices And Digital Biomarkers” »

𝙎𝙡𝙚𝙚𝙥 𝙢𝙖𝙮 𝙗𝙚 𝙤𝙣𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙢𝙤𝙨𝙩 𝙥𝙤𝙩𝙚𝙣𝙩 𝙢𝙚𝙙𝙞𝙘𝙞𝙣𝙚𝙨 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙗𝙧𝙖𝙞𝙣, 𝙨𝙘𝙞𝙚𝙣𝙩𝙞𝙨𝙩𝙨 𝙖𝙧𝙚 𝙙𝙞𝙨𝙘𝙤𝙫𝙚𝙧𝙞𝙣𝙜, 𝙖𝙨 𝙩𝙝𝙚𝙮 𝙚𝙭𝙥𝙡𝙤𝙧𝙚 𝙩𝙝𝙚 𝙞𝙣𝙣𝙚𝙧 𝙡𝙖𝙗𝙮𝙧𝙞𝙣𝙩𝙝𝙨 𝙤𝙛 𝙩𝙝𝙚 𝙩𝙝𝙧𝙚𝙚-𝙥𝙤𝙪𝙣𝙙 𝙤𝙧𝙜𝙖𝙣 𝙙𝙪𝙧𝙞𝙣𝙜 𝙙𝙚𝙚𝙥 𝙨𝙡𝙚𝙚𝙥 𝙖𝙣𝙙 𝙙𝙧𝙚𝙖𝙢 𝙘𝙮𝙘𝙡𝙚𝙨 𝙞𝙣 𝙗𝙤𝙩𝙝 𝙝𝙚𝙖𝙡𝙩𝙝 𝙖𝙣𝙙 𝙙𝙞𝙨𝙚𝙖𝙨𝙚.

The Neuro-Network.

𝐂𝐚𝐧 𝐝𝐞𝐞𝐩 𝐬𝐥𝐞𝐞𝐩 𝐡𝐞𝐥𝐩 𝐝𝐞𝐯𝐚𝐬𝐭𝐚𝐭𝐢𝐧𝐠 𝐛𝐫𝐚𝐢𝐧 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬? 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭𝐬 𝐬𝐭𝐮𝐝𝐲𝐢𝐧𝐠 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐟𝐢𝐧𝐝 𝐨𝐮𝐭

Continue reading “Can deep sleep help devastating brain disorders? Scientists studying Parkinson’s want to find out” »

New videos DAILY: https://bigth.ink/youtube.
Join Big Think Edge for exclusive videos: https://bigth.ink/Edge.

ABOUT BIG THINK:

Continue reading “Ray Kurzweil on Preparing For the Singularity” »

Watch the newest video from Big Think: https://bigth.ink/NewVideo.
Join Big Think Edge for exclusive videos: https://bigth.ink/Edge.

ABOUT BIG THINK:

Continue reading “Ray Kurzweil: Your Brain in the Cloud” »

Safed’s Ziv Medical Center has sent a letter to Health Ministry director Nachman Ash requesting he grant emergency authorization for the anti-COVID drug Amor 18 developed by the Israeli company Amorphical in order to treat patients in moderate to serious condition due to the coronavirus, Channel 2 reported Friday.

In letter to Health Ministry director, Ziv Medical Center points to promising results from Amor 18’s clinical trial, where all patients who received drug went on to recover (drug uses Amorphous Calcium Carbonate: ACC).

Israeli biotech company Amorphical recently published what it says are promising results from the second stage of its Amor 18 clinical study.

Continue reading “Hospital seeks emergency approval of Israeli COVID drug for moderate-seriously ill” »

Innovating Life-Saving Therapeutic Devices — Dr. Amy Throckmorton, PhD — BioCirc Research Laboratory, Drexel University School of Biomedical Engineering, Science and Health Systems.

Dr. Amy Throckmorton, Ph.D. (https://drexel.edu/biomed/faculty/core/ThrockmortonAmy/) is Associate Professor and Director of the BioCirc Research Laboratory, in the School of Biomedical Engineering, Science and Health Systems, at Drexel University.

Continue reading “Dr. Amy Throckmorton, PhD — BioCirc / Drexel University — Innovating Life-Saving Therapeutic Devices” »

𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝𝙚𝙧𝙨 𝙛𝙧𝙤𝙢 𝙏𝙝𝙚 𝙐𝙣𝙞𝙫𝙚𝙧𝙨𝙞𝙩𝙮 𝙤𝙛 𝙏𝙚𝙭𝙖𝙨 𝙖𝙩 𝘿𝙖𝙡𝙡𝙖𝙨 𝙖𝙣𝙙 𝙩𝙝𝙚𝙞𝙧 𝙘𝙤𝙡𝙡𝙚𝙖𝙜𝙪𝙚𝙨 𝙝𝙖𝙫𝙚 𝙙𝙞𝙨𝙘𝙤𝙫𝙚𝙧𝙚𝙙 𝙩𝙝𝙖𝙩 𝙗𝙧𝙚𝙖𝙩𝙝𝙞𝙣𝙜 𝙧𝙖𝙩𝙚𝙨 𝙬𝙝𝙞𝙡𝙚 𝙨𝙡𝙚𝙚𝙥𝙞𝙣𝙜 𝙘𝙖𝙣 𝙗𝙚 𝙪𝙨𝙚𝙙 𝙩𝙤 𝙙𝙞𝙨𝙩𝙞𝙣𝙜𝙪𝙞𝙨𝙝 𝙘𝙤𝙜𝙣𝙞𝙩𝙞𝙫𝙚𝙡𝙮 𝙣𝙤𝙧𝙢𝙖𝙡 𝙥𝙚𝙤𝙥𝙡𝙚 𝙛𝙧𝙤𝙢 𝙩𝙝𝙤𝙨𝙚 𝙬𝙝𝙤 𝙝𝙖𝙫𝙚 𝙢𝙞𝙡𝙙 𝙘𝙤𝙜𝙣𝙞𝙩𝙞𝙫𝙚 𝙞𝙢𝙥𝙖𝙞𝙧𝙢𝙚𝙣𝙩 𝙤𝙧 𝘼𝙡𝙯𝙝𝙚𝙞𝙢𝙚𝙧’𝙨 𝙙𝙞𝙨𝙚𝙖𝙨𝙚.

The Neuro-Network.

𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐓𝐞𝐱𝐚𝐬 𝐚𝐭 𝐃𝐚𝐥𝐥𝐚𝐬:

Continue reading “Study: Reducing Snoring May Help Put Brain Health Risks to Rest” »

For the past decade, AI has been quietly seeping into daily life, from facial recognition to digital assistants like Siri or Alexa. These largely unregulated uses of AI are highly lucrative for those who control them but are already causing real-world harms to those who are subjected to them: false arrests; health care discrimination; and a rise in pervasive surveillance that, in the case of policing, can disproportionately affect Black people and disadvantaged socioeconomic groups.

Gebru is a leading figure in a constellation of scholars, activists, regulators, and technologists collaborating to reshape ideas about what AI is and what it should be. Some of her fellow travelers remain in Big Tech, mobilizing those insights to push companies toward AI that is more ethical. Others, making policy on both sides of the Atlantic, are preparing new rules to set clearer limits on the companies benefiting most from automated abuses of power. Gebru herself is seeking to push the AI world beyond the binary of asking whether systems are biased and to instead focus on power: who’s building AI, who benefits from it, and who gets to decide what its future looks like.

Full Story:

Continue reading “Why Timnit Gebru Isn’t Waiting for Big Tech to Fix AI’s Problems” »